A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Kenji Ina, Yuko Kato, Kengo Nanya, Satoshi Hibi, Yuko Shirokawa, Tomoko Toda, Satoshi Kayukawa, Adaptation to the Progress in Cancer Genomic Medicine by a Japanese Community Hospital , Journal of Cancer Research Updates: Vol. 12 (2023)
- Kaiguo Yan, Laura Doyle, Haisong Liu, Pramila Rani Anne, Amy Harrison, Yan Yu, Junsheng Cao, Template-Based Inverse PlanningSimulated Annealing for CT-Based High-Dose-Rate Brachytherapy of Cervical Cancer: Feasibility Study , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- Willy Ramos, Víctor Juan Vera-Ponce, Rubén Espinoza, Nadia Guerrero, Zoila Moreno Garrido, Fiorella E. Zuzunaga-Montoya, Ericson L. Gutierrez, Non-Performance of Cancer Screening in Peru: A Comparative Analysis between Regions Exposed and Unexposed to Ozone Layer Mini-Hole , Journal of Cancer Research Updates: Vol. 14 (2025)
- Pravin K. Naoghare, Ajam Shekh, Amit Bafana, Kannan Krishnamurthi, Saravanadevi Sivanesan, Unveiling the Unpredicted and Uncontrolled Metastasis of Cancer Cells: A Minireview , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- Umesh C. Gupta, Subhas C. Gupta, Shayle S. Gupta, The Under appreciated Role of Lifestyle and Nutrition in Cancer Prevention, Genesis, and Treatment , Journal of Cancer Research Updates: Vol. 7 No. 4 (2018)
- Ricardo Hsieh, The Role of BRAF Gene in Cancer: Literature Review and Future Directions , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Jianwei Zhao, Yongxiu Chen, Xiaoxiao Lu, Di Wu, Jiansong Chen, Zhihuang Chen, Lin Liu, Lei Yang, Lan Zhang, Yifeng Zhou, Jiachun Lu, The Polymorphism of EME1 Gene is Associated with an Increased Risk of Lung Cancer: A Case-Control Study from Chinese Population , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
- F. Gloria-Bottini, M. Nicotra, C. Spina, P.L. Benedetti-Panici, P. Saccucci, A. Neri, A. Magrini, E. Bottini, P53 Codon 72 and Endometrium Cancer , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Kawakeb N. Abdulla, Rasha Kareem Khudhur, Ali Muafaq Said, Azal Hamoody Jumaa, Youssef Shakuri Yasin, Laetrile and Methotrexate: A Dual-Drug Approach to Inhibiting Cervical Cancer Cell Proliferation , Journal of Cancer Research Updates: Vol. 14 (2025)
- Fatma F. Abdel Hamid, Mahmoud K. Singer, Mahmoud N. El-Rouby, Mahmoud M. Said, Reda H. Tabashy, Motawa E. El-Houseini, HepG2 Attenuation Induced by RNase A Modulates Gene Profiling and Immunophenotypic Characterization of Some Immune Cells Operating in Cancer Vaccine , Journal of Cancer Research Updates: Vol. 7 No. 1 (2018)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)